Certificate pursuant to Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018
Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011
Disclosure under Regulation 30 – Demand Notice
Intimation of Closure of Trading Window – March 2026
Allotment of Equity Shares under Thyrocare Employee Stock Option Scheme of the Company on March 02, 2026
Additional Capital infusion in Thyrocare Laboratories (Tanzania) Limited – February 24, 2026
Intimation of receipt of Awards
Change of Name of M S K A & Associates (“Statutory Auditor”) Upon Conversion of Firm into LLP
Appointment of Mr. Rajdeep Panwar as Chief Commercial Officer
Appointment of Dr. Ramesh Kinha as Chief Operating Officer
Allotment of Bonus Equity Shares
Resignation of Mr. Nitin Chugh, Chief Commercial Officer and Senior Management Personnel
Intimation for Record date for Bonus Issue of the Company
Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 – Amendments to Memorandum and Articles of Association.
Disclosures regarding Declaration of Interim Dividend, Record Date for Interim Dividend, Issuance of Bonus Shares and Allotment of Equity Shares under Thyrocare Employee Stock Option Scheme of the Company.
Grant Of Employee Stock Options Under Thyrocare Employee Stock Option Scheme.
Disclosure under Regulation 30A of LODR
Intimation regarding the appointment of Mr. Rahul Guha, Managing Director and Chief Executive Officer of the Company, as Managing Director and Chief Executive Officer of API Holdings Limited, Ultimate Holding Company.
Change of Code of Conduct of the Company of the Regulating, Monitoring and Reporting of Trading by Designated Persons and their Immediate Relatives under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
Change in Directorate
Change in Chief Financial Officer (CFO)
Record Date Intimation for final Dividend
Disclosure Under Regulation 30 of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
Closure of Trading Window – July 01, 2025
Newspaper advertisements – June 17, 2025
Additional Equity infusion in Thyrocare Laboratories (Tanzania) Limited – Joint Venture – June 03, 2025
Allotment of 996 Equity Shares pursuant to the Employee Stock Option Scheme (ESOS) of the Company
Appointment of Secretarial Auditors and Re-appointment of Cost Auditor
Closure of Trading Window – April 01, 2025
Additional Equity infusion in Thyrocare Laboratories (Tanzania) Limited – Joint Venture
